Sign-up Here

Welcome, Guest
My Account
Log In

Endo Pharmaceuticals

Number of Articles Found: 59

1. Watson's Opana ANDA Triggers Endo, Penwest Suit

Tuesday, Mar 09, 2010

Watson Pharmaceuticals Inc. has revealed that it is facing a patent infringement suit from Endo Pharmaceuticals Inc. and Penwest Pharmaceuticals Co. following the generics maker's bid for approval of its own version of painkiller Opana ER.

2. Genzyme, Daiichi Try To Halt Impax’s Generic Welchol

Friday, Jan 15, 2010

Genzyme Corp. and Daiichi Sankyo Inc. have dragged Impax Laboratories to court in an effort to block it from marketing a generic version of their cholesterol drug Welchol.

3. Former Indevus VP Agrees To Insider Trading Deal

Monday, Jan 11, 2010

A former vice president of Indevus Pharmaceuticals Inc. has agreed to pay the U.S. Securities and Exchange Commission over $130,000 to settle insider trading allegations brought by regulators who accused the executive of dumping stock after learning approval of one of the biotechnology company's drugs was to be delayed.

4. Q&A With Burns & Levinson's Josef Volman

Tuesday, Dec 22, 2009

Many clients are looking to the global market for manufacturing, sales, marketing and strategic partnerships. This global reach forces companies to address international intellectual property issues, dispute resolution and other contract negotiation issues, says Josef B. Volman, co-chair of the corporate practice group at Burns & Levinson LLP.

5. FDA Issues Warning On Voltaren Gel Liver Risks

Monday, Dec 07, 2009

The U.S. Food and Drug Administration has issued a warning to health care professionals that Novartis AG and Endo Pharmaceuticals Inc.'s topical pain reliever Voltaren Gel carries a risk of potentially fatal liver damage, including organ failure.

6. Endo To Pay $23M To Settle Patent Suit Over Patch

Wednesday, Nov 11, 2009

Endo Pharmaceuticals Inc. announced Wednesday that it would pay patent-holding company LecTec Corp. $23 million to settle a suit that accused the drugmaker of infringing two patents related to adhesive patches.

7. Genzyme Sues Endo In Latest Renagel ANDA Suit

Tuesday, Oct 06, 2009

Genzyme Corp. has accused Endo Pharmaceuticals Inc. of infringing a patent for Renagel by seeking regulatory permission to sell a generic version of the kidney disease treatment in the U.S. before the patent expires.

8. Endo Looks To Join Genzyme-Impax Renagel Battle

Thursday, Sep 03, 2009

Endo Pharmaceuticals Inc. has asked a court for permission to intervene in Genzyme Corp.'s Renagel patent infringement case against Impax Laboratories Inc., arguing that Impax challenged a second patent's validity solely in a bid to force first-filer Endo to forfeit its exclusivity period.

9. FDA Orders Stronger Warning For Propoxyphene

Tuesday, Jul 07, 2009

The U.S. Food and Drug Administration has ordered manufacturers of drugs containing the pain-killing ingredient propoxyphene to boost the products' warning labels to highlight the risk of fatal overdoses.

10. FDA Panel Pushes Acetaminophen Painkiller Ban

Wednesday, Jul 01, 2009

Popular prescription painkillers including Abbott Laboratories' Vicodin and Endo Pharmaceuticals Holdings Inc.'s Percocet may soon be pulled from the market, after a narrow majority of U.S. Food and Drug Administration advisory panel members reportedly voted Tuesday to eliminate the drugs because they contain acetaminophen, which has been linked to liver damage and death.

11. FTC Pushes Congress To Pass Drug Settlement Bill

Wednesday, Jun 03, 2009

A top Federal Trade Commission official on Wednesday urged lawmakers to pass legislation banning so-called reverse payment patent settlements between brand-name pharmaceutical companies and their generic competitors.

12. Sandoz, Ratiopharm Infringe Oxycontin Patents: Court

Wednesday, Apr 01, 2009

A U.K. appeals court has determined that generic-drug makers Sandoz Ltd. and ratiopharm GmbH have infringed the patents of Purdue Pharma LP affiliate Napp Pharmaceutical Holdings Ltd. for the painkiller Oxycontin.

13. Oxycodone Method Obvious: Fed Circ.

Thursday, Mar 12, 2009

An appeals court on Wednesday affirmed a U.S. Board of Patent Appeals ruling that a potentially less toxic method for preparing the pain reliever oxycodone was obvious, barring both parties in the dispute – who each claim to have discovered the process – from moving forward with their respective patent applications.

14. Endo, Actavis Settle Spat Over Painkiller Patents

Thursday, Feb 19, 2009

Endo Pharmaceuticals Inc. and Penwest Pharmaceuticals Co. have reached a settlement with Actavis South Atlantic LLC in a patent infringement suit over Actavis' attempt to make and market a generic version of pain medication Opana ER.

15. Indevus, Endo Face Another Class Action Over Merger

Tuesday, Feb 03, 2009

Indevus Pharmaceuticals Inc. is facing another proposed shareholder class action seeking to block a merger with Endo Pharmaceuticals Holdings Inc., claiming Endo's $4.50 a share offer undervalues the specialty drug company.

16. IP Practice: Dechert

Wednesday, Jan 21, 2009

Difficulties in obtaining injunctive relief in federal court coupled with the increasing number of foreign companies involved in patent litigation are boosting cases at the U.S. International Trade Commission, making legal experience in that forum more important than ever, according to Martin J. Black, chairman of Dechert LLP’s intellectual property group.

17. Indevus Investors Sue To Halt Endo Merger

Wednesday, Jan 14, 2009

Indevus Pharmaceuticals Inc. has been hit with two putative class actions by shareholders alleging the specialty drug company and its executives breached their fiduciary duties in connection with a merger proposal by Endo Pharmaceuticals Holdings Inc.

1 \| 2 \| 3

1 | 2 | 3